Table of Content

1 Report Overview
1.1 Human Insulin Definition
1.2 Market by Type
1.2.1 Global Human Insulin Market Size Growth Rate by Type, 2018 VS 2024 VS 2034
1.2.2 Insulin Analogs and Biosimilars
1.2.3 Human Insulin Biologics
1.3 Market Segment by Application
1.3.1 Global Human Insulin Market Size Growth Rate by Application, 2018 VS 2024 VS 2034
1.3.2 Short Acting
1.3.3 Intermediate Acting
1.3.4 Long Acting
1.3.5 Pre-Mix Insulin
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Human Insulin Sales
2.1 Global Human Insulin Revenue Estimates and Forecasts 2018-2034
2.2 Global Human Insulin Revenue by Region: 2018 VS 2024 VS 2034
2.3 Global Human Insulin Revenue by Region
2.3.1 Global Human Insulin Revenue by Region (2018-2023)
2.3.2 Global Human Insulin Revenue by Region (2024-2034)
2.4 Global Human Insulin Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Human Insulin Sales Quantity by Region: 2018 VS 2024 VS 2034
2.6 Global Human Insulin Sales Quantity by Region
2.6.1 Global Human Insulin Sales Quantity by Region (2018-2023)
2.6.2 Global Human Insulin Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Human Insulin Sales Quantity by Manufacturers
3.1.1 Global Human Insulin Sales Quantity by Manufacturers (2018-2023)
3.1.2 Global Human Insulin Sales Quantity Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Companies by Human Insulin Sales in 2024
3.2 Global Human Insulin Revenue by Manufacturers
3.2.1 Global Human Insulin Revenue by Manufacturers (2018-2023)
3.2.2 Global Human Insulin Revenue Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Human Insulin Revenue in 2024
3.3 Global Human Insulin Sales Price by Manufacturers
3.4 Global Key Players of Human Insulin, Industry Ranking, 2021 VS 2024
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Human Insulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Human Insulin, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Human Insulin, Product Offered and Application
3.8 Global Key Manufacturers of Human Insulin, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Human Insulin Sales Quantity by Type
4.1.1 Global Human Insulin Historical Sales Quantity by Type (2018-2023)
4.1.2 Global Human Insulin Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Human Insulin Sales Quantity Market Share by Type (2018-2034)
4.2 Global Human Insulin Revenue by Type
4.2.1 Global Human Insulin Historical Revenue by Type (2018-2023)
4.2.2 Global Human Insulin Forecasted Revenue by Type (2024-2034)
4.2.3 Global Human Insulin Revenue Market Share by Type (2018-2034)
4.3 Global Human Insulin Price by Type
4.3.1 Global Human Insulin Price by Type (2018-2023)
4.3.2 Global Human Insulin Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Human Insulin Sales Quantity by Application
5.1.1 Global Human Insulin Historical Sales Quantity by Application (2018-2023)
5.1.2 Global Human Insulin Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Human Insulin Sales Quantity Market Share by Application (2018-2034)
5.2 Global Human Insulin Revenue by Application
5.2.1 Global Human Insulin Historical Revenue by Application (2018-2023)
5.2.2 Global Human Insulin Forecasted Revenue by Application (2024-2034)
5.2.3 Global Human Insulin Revenue Market Share by Application (2018-2034)
5.3 Global Human Insulin Price by Application
5.3.1 Global Human Insulin Price by Application (2018-2023)
5.3.2 Global Human Insulin Price Forecast by Application (2024-2034)
6 North America
6.1 North America Human Insulin Sales by Company
6.1.1 North America Human Insulin Revenue by Company (2018-2023)
6.1.2 North America Human Insulin Sales Quantity by Company (2018-2023)
6.2 North America Human Insulin Market Size by Type
6.2.1 North America Human Insulin Sales Quantity by Type (2018-2034)
6.2.2 North America Human Insulin Revenue by Type (2018-2034)
6.3 North America Human Insulin Market Size by Application
6.3.1 North America Human Insulin Sales Quantity by Application (2018-2034)
6.3.2 North America Human Insulin Revenue by Application (2018-2034)
6.4 North America Human Insulin Market Size by Country
6.4.1 North America Human Insulin Revenue by Country: 2018 VS 2024 VS 2034
6.4.2 North America Human Insulin Revenue by Country (2018-2034)
6.4.3 North America Human Insulin Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Human Insulin Sales by Company
7.1.1 Europe Human Insulin Sales Quantity by Company (2018-2023)
7.1.2 Europe Human Insulin Revenue by Company (2018-2023)
7.2 Europe Human Insulin Market Size by Type
7.2.1 Europe Human Insulin Sales Quantity by Type (2018-2034)
7.2.2 Europe Human Insulin Revenue by Type (2018-2034)
7.3 Europe Human Insulin Market Size by Application
7.3.1 Europe Human Insulin Sales Quantity by Application (2018-2034)
7.3.2 Europe Human Insulin Revenue by Application (2018-2034)
7.4 Europe Human Insulin Market Size by Country
7.4.1 Europe Human Insulin Revenue by Country: 2018 VS 2024 VS 2034
7.4.2 Europe Human Insulin Revenue by Country (2018-2034)
7.4.3 Europe Human Insulin Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Human Insulin Sales by Company
8.1.1 China Human Insulin Sales Quantity by Company (2018-2023)
8.1.2 China Human Insulin Revenue by Company (2018-2023)
8.2 China Human Insulin Market Size by Type
8.2.1 China Human Insulin Sales Quantity by Type (2018-2034)
8.2.2 China Human Insulin Revenue by Type (2018-2034)
8.3 China Human Insulin Market Size by Application
8.3.1 China Human Insulin Sales Quantity by Application (2018-2034)
8.3.2 China Human Insulin Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Human Insulin Sales by Company
9.1.1 APAC Human Insulin Sales Quantity by Company (2018-2023)
9.1.2 APAC Human Insulin Revenue by Company (2018-2023)
9.2 APAC Human Insulin Market Size by Type
9.2.1 APAC Human Insulin Sales Quantity by Type (2018-2034)
9.2.2 APAC Human Insulin Revenue by Type (2018-2034)
9.3 APAC Human Insulin Market Size by Application
9.3.1 APAC Human Insulin Sales Quantity by Application (2018-2034)
9.3.2 APAC Human Insulin Revenue by Application (2018-2034)
9.4 APAC Human Insulin Market Size by Region
9.4.1 APAC Human Insulin Revenue by Region: 2018 VS 2024 VS 2034
9.4.2 APAC Human Insulin Revenue by Region (2018-2034)
9.4.3 APAC Human Insulin Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Human Insulin Sales by Company
10.1.1 Middle East, Africa and Latin America Human Insulin Sales Quantity by Company (2018-2023)
10.1.2 Middle East, Africa and Latin America Human Insulin Revenue by Company (2018-2023)
10.2 Middle East, Africa and Latin America Human Insulin Market Size by Type
10.2.1 Middle East, Africa and Latin America Human Insulin Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Human Insulin Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Human Insulin Market Size by Application
10.3.1 Middle East, Africa and Latin America Human Insulin Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Human Insulin Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Human Insulin Market Size by Country
10.4.1 Middle East, Africa and Latin America Human Insulin Revenue by Country: 2018 VS 2024 VS 2034
10.4.2 Middle East, Africa and Latin America Human Insulin Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Human Insulin Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 B. Braun
11.1.1 B. Braun Company Information
11.1.2 B. Braun Overview
11.1.3 B. Braun Human Insulin Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.1.4 B. Braun Human Insulin Products and Services
11.1.5 B. Braun Human Insulin SWOT Analysis
11.1.6 B. Braun Recent Developments
11.2 Becton, Dickinson
11.2.1 Becton, Dickinson Company Information
11.2.2 Becton, Dickinson Overview
11.2.3 Becton, Dickinson Human Insulin Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.2.4 Becton, Dickinson Human Insulin Products and Services
11.2.5 Becton, Dickinson Human Insulin SWOT Analysis
11.2.6 Becton, Dickinson Recent Developments
11.3 Biocon
11.3.1 Biocon Company Information
11.3.2 Biocon Overview
11.3.3 Biocon Human Insulin Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.3.4 Biocon Human Insulin Products and Services
11.3.5 Biocon Human Insulin SWOT Analysis
11.3.6 Biocon Recent Developments
11.4 Biodel
11.4.1 Biodel Company Information
11.4.2 Biodel Overview
11.4.3 Biodel Human Insulin Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.4.4 Biodel Human Insulin Products and Services
11.4.5 Biodel Human Insulin SWOT Analysis
11.4.6 Biodel Recent Developments
11.5 ELI Lilly
11.5.1 ELI Lilly Company Information
11.5.2 ELI Lilly Overview
11.5.3 ELI Lilly Human Insulin Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.5.4 ELI Lilly Human Insulin Products and Services
11.5.5 ELI Lilly Human Insulin SWOT Analysis
11.5.6 ELI Lilly Recent Developments
11.6 Julphar
11.6.1 Julphar Company Information
11.6.2 Julphar Overview
11.6.3 Julphar Human Insulin Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.6.4 Julphar Human Insulin Products and Services
11.6.5 Julphar Human Insulin SWOT Analysis
11.6.6 Julphar Recent Developments
11.7 NOVO Nordisk
11.7.1 NOVO Nordisk Company Information
11.7.2 NOVO Nordisk Overview
11.7.3 NOVO Nordisk Human Insulin Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.7.4 NOVO Nordisk Human Insulin Products and Services
11.7.5 NOVO Nordisk Human Insulin SWOT Analysis
11.7.6 NOVO Nordisk Recent Developments
11.8 Sanofi
11.8.1 Sanofi Company Information
11.8.2 Sanofi Overview
11.8.3 Sanofi Human Insulin Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.8.4 Sanofi Human Insulin Products and Services
11.8.5 Sanofi Human Insulin SWOT Analysis
11.8.6 Sanofi Recent Developments
11.9 Wockhardt
11.9.1 Wockhardt Company Information
11.9.2 Wockhardt Overview
11.9.3 Wockhardt Human Insulin Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.9.4 Wockhardt Human Insulin Products and Services
11.9.5 Wockhardt Human Insulin SWOT Analysis
11.9.6 Wockhardt Recent Developments
11.10 Ypsomed
11.10.1 Ypsomed Company Information
11.10.2 Ypsomed Overview
11.10.3 Ypsomed Human Insulin Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.10.4 Ypsomed Human Insulin Products and Services
11.10.5 Ypsomed Human Insulin SWOT Analysis
11.10.6 Ypsomed Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Human Insulin Value Chain Analysis
12.2 Human Insulin Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Human Insulin Production Mode & Process
12.4 Human Insulin Sales and Marketing
12.4.1 Human Insulin Sales Channels
12.4.2 Human Insulin Distributors
12.5 Human Insulin Customers
13 Market Dynamics
13.1 Human Insulin Industry Trends
13.2 Human Insulin Market Drivers
13.3 Human Insulin Market Challenges
13.4 Human Insulin Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Human Insulin Market Size Growth Rate (CAGR) by Type, 2018 VS 2024 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Insulin Analogs and Biosimilars
Table 3. Major Manufacturers of Human Insulin Biologics
Table 4. Global Human Insulin Market Size Growth Rate (CAGR) by Application, 2018 VS 2024 VS 2034 (US$ Million)
Table 5. Global Human Insulin Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 6. Global Human Insulin Revenue by Region (2018-2023) & (US$ Million)
Table 7. Global Human Insulin Revenue Market Share by Region (2018-2023)
Table 8. Global Human Insulin Revenue by Region (2024-2034) & (US$ Million)
Table 9. Global Human Insulin Revenue Market Share by Region (2024-2034)
Table 10. Global Human Insulin Sales Quantity by Region: 2018 VS 2024 VS 2034 (K Doses)
Table 11. Global Human Insulin Sales by Region (2018-2023) & (K Doses)
Table 12. Global Human Insulin Sales Market Share by Region (2018-2023)
Table 13. Global Human Insulin Sales by Region (2024-2034) & (K Doses)
Table 14. Global Human Insulin Sales Market Share by Region (2024-2034)
Table 15. Global Human Insulin Sales Quantity by Manufacturers (2018-2023) & (K Doses)
Table 16. Global Human Insulin Sales Quantity Share by Manufacturers (2018-2023)
Table 17. Global Human Insulin Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 18. Global Human Insulin Revenue Share by Manufacturers (2018-2023)
Table 19. Global Human Insulin Price by Manufacturers 2018-2023 (USD/Dose)
Table 20. Global Key Players of Human Insulin, Industry Ranking, 2021 VS 2024
Table 21. Global Human Insulin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Human Insulin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Insulin as of 2024)
Table 23. Global Key Manufacturers of Human Insulin, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Human Insulin, Product Offered and Application
Table 25. Global Key Manufacturers of Human Insulin, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Human Insulin Sales Quantity by Type (2018-2023) & (K Doses)
Table 28. Global Human Insulin Sales Quantity by Type (2024-2034) & (K Doses)
Table 29. Global Human Insulin Sales Quantity Share by Type (2018-2023)
Table 30. Global Human Insulin Sales Quantity Share by Type (2024-2034)
Table 31. Global Human Insulin Revenue by Type (2018-2023) & (US$ Million)
Table 32. Global Human Insulin Revenue by Type (2024-2034) & (US$ Million)
Table 33. Global Human Insulin Revenue Share by Type (2018-2023)
Table 34. Global Human Insulin Revenue Share by Type (2024-2034)
Table 35. Human Insulin Price by Type (2018-2023) & (USD/Dose)
Table 36. Global Human Insulin Price Forecast by Type (2024-2034) & (USD/Dose)
Table 37. Global Human Insulin Sales Quantity by Application (2018-2023) & (K Doses)
Table 38. Global Human Insulin Sales Quantity by Application (2024-2034) & (K Doses)
Table 39. Global Human Insulin Sales Quantity Share by Application (2018-2023)
Table 40. Global Human Insulin Sales Quantity Share by Application (2024-2034)
Table 41. Global Human Insulin Revenue by Application (2018-2023) & (US$ Million)
Table 42. Global Human Insulin Revenue by Application (2024-2034) & (US$ Million)
Table 43. Global Human Insulin Revenue Share by Application (2018-2023)
Table 44. Global Human Insulin Revenue Share by Application (2024-2034)
Table 45. Human Insulin Price by Application (2018-2023) & (USD/Dose)
Table 46. Global Human Insulin Price Forecast by Application (2024-2034) & (USD/Dose)
Table 47. North America Human Insulin Revenue by Company (2018-2023) & (US$ Million)
Table 48. North America Human Insulin Sales Quantity by Company (2018-2023) & (K Doses)
Table 49. North America Human Insulin Sales Quantity by Type (2018-2023) & (K Doses)
Table 50. North America Human Insulin Sales Quantity by Type (2024-2034) & (K Doses)
Table 51. North America Human Insulin Revenue by Type (2018-2023) & (US$ Million)
Table 52. North America Human Insulin Revenue by Type (2024-2034) & (US$ Million)
Table 53. North America Human Insulin Sales Quantity by Application (2018-2023) & (K Doses)
Table 54. North America Human Insulin Sales Quantity by Application (2024-2034) & (K Doses)
Table 55. North America Human Insulin Revenue by Application (2018-2023) & (US$ Million)
Table 56. North America Human Insulin Revenue by Application (2024-2034) & (US$ Million)
Table 57. North America Human Insulin Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 58. North America Human Insulin Revenue by Country (2018-2023) & (US$ Million)
Table 59. North America Human Insulin Revenue by Country (2024-2034) & (US$ Million)
Table 60. North America Human Insulin Sales Quantity by Country (2018-2023) & (K Doses)
Table 61. North America Human Insulin Sales Quantity by Country (2024-2034) & (K Doses)
Table 62. Europe Human Insulin Sales Quantity by Company (2018-2023) & (K Doses)
Table 63. Europe Human Insulin Revenue by Company (2018-2023) & (US$ Million)
Table 64. Europe Human Insulin Sales Quantity by Type (2018-2023) & (K Doses)
Table 65. Europe Human Insulin Sales Quantity by Type (2024-2034) & (K Doses)
Table 66. Europe Human Insulin Revenue by Type (2018-2023) & (US$ Million)
Table 67. Europe Human Insulin Revenue by Type (2024-2034) & (US$ Million)
Table 68. Europe Human Insulin Sales Quantity by Application (2018-2023) & (K Doses)
Table 69. Europe Human Insulin Sales Quantity by Application (2024-2034) & (K Doses)
Table 70. Europe Human Insulin Revenue by Application (2018-2023) & (US$ Million)
Table 71. Europe Human Insulin Revenue by Application (2024-2034) & (US$ Million)
Table 72. Europe Human Insulin Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 73. Europe Human Insulin Revenue by Country (2018-2023) & (US$ Million)
Table 74. Europe Human Insulin Revenue by Country (2024-2034) & (US$ Million)
Table 75. Europe Human Insulin Sales Quantity by Country (2018-2023) & (K Doses)
Table 76. Europe Human Insulin Sales Quantity by Country (2024-2034) & (K Doses)
Table 77. China Human Insulin Sales Quantity by Company (2018-2023) & (K Doses)
Table 78. China Human Insulin Revenue by Company (2018-2023) & (US$ Million)
Table 79. China Human Insulin Sales Quantity by Type (2018-2023) & (K Doses)
Table 80. China Human Insulin Sales Quantity by Type (2024-2034) & (K Doses)
Table 81. China Human Insulin Revenue by Type (2018-2023) & (US$ Million)
Table 82. China Human Insulin Revenue by Type (2024-2034) & (US$ Million)
Table 83. China Human Insulin Sales Quantity by Application (2018-2023) & (K Doses)
Table 84. China Human Insulin Sales Quantity by Application (2024-2034) & (K Doses)
Table 85. China Human Insulin Revenue by Application (2018-2023) & (US$ Million)
Table 86. China Human Insulin Revenue by Application (2024-2034) & (US$ Million)
Table 87. APAC Human Insulin Sales Quantity by Company (2018-2023) & (K Doses)
Table 88. APAC Human Insulin Revenue by Company (2018-2023) & (US$ Million)
Table 89. APAC Human Insulin Sales Quantity by Type (2018-2023) & (K Doses)
Table 90. APAC Human Insulin Sales Quantity by Type (2024-2034) & (K Doses)
Table 91. APAC Human Insulin Revenue by Type (2018-2023) & (US$ Million)
Table 92. APAC Human Insulin Revenue by Type (2024-2034) & (US$ Million)
Table 93. APAC Human Insulin Sales Quantity by Application (2018-2023) & (K Doses)
Table 94. APAC Human Insulin Sales Quantity by Application (2024-2034) & (K Doses)
Table 95. APAC Human Insulin Revenue by Application (2018-2023) & (US$ Million)
Table 96. APAC Human Insulin Revenue by Application (2024-2034) & (US$ Million)
Table 97. APAC Human Insulin Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 98. APAC Human Insulin Revenue by Region (2018-2023) & (US$ Million)
Table 99. APAC Human Insulin Revenue by Region (2024-2034) & (US$ Million)
Table 100. APAC Human Insulin Sales Quantity by Region (2018-2023) & (K Doses)
Table 101. APAC Human Insulin Sales Quantity by Region (2024-2034) & (K Doses)
Table 102. Middle East, Africa and Latin America Human Insulin Sales Quantity by Company (2018-2023) & (K Doses)
Table 103. Middle East, Africa and Latin America Human Insulin Revenue by Company (2018-2023) & (US$ Million)
Table 104. Middle East, Africa and Latin America Human Insulin Sales Quantity by Type (2018-2023) & (K Doses)
Table 105. Middle East, Africa and Latin America Human Insulin Sales Quantity by Type (2024-2034) & (K Doses)
Table 106. Middle East, Africa and Latin America Human Insulin Revenue by Type (2018-2023) & (US$ Million)
Table 107. Middle East, Africa and Latin America Human Insulin Revenue by Type (2024-2034) & (US$ Million)
Table 108. Middle East, Africa and Latin America Human Insulin Sales Quantity by Application (2018-2023) & (K Doses)
Table 109. Middle East, Africa and Latin America Human Insulin Sales Quantity by Application (2024-2034) & (K Doses)
Table 110. Middle East, Africa and Latin America Human Insulin Revenue by Application (2018-2023) & (US$ Million)
Table 111. Middle East, Africa and Latin America Human Insulin Revenue by Application (2024-2034) & (US$ Million)
Table 112. Middle East, Africa and Latin America Human Insulin Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 113. Middle East, Africa and Latin America Human Insulin Revenue by Country (2018-2023) & (US$ Million)
Table 114. Middle East, Africa and Latin America Human Insulin Revenue by Country (2024-2034) & (US$ Million)
Table 115. Middle East, Africa and Latin America Human Insulin Sales Quantity by Country (2018-2023) & (K Doses)
Table 116. Middle East, Africa and Latin America Human Insulin Sales Quantity by Country (2024-2034) & (K Doses)
Table 117. B. Braun Company Information
Table 118. B. Braun Description and Overview
Table 119. B. Braun Human Insulin Sales Quantity (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2018-2023)
Table 120. B. Braun Human Insulin Product and Services
Table 121. B. Braun Human Insulin SWOT Analysis
Table 122. B. Braun Recent Developments
Table 123. Becton, Dickinson Company Information
Table 124. Becton, Dickinson Description and Overview
Table 125. Becton, Dickinson Human Insulin Sales Quantity (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2018-2023)
Table 126. Becton, Dickinson Human Insulin Product and Services
Table 127. Becton, Dickinson Human Insulin SWOT Analysis
Table 128. Becton, Dickinson Recent Developments
Table 129. Biocon Company Information
Table 130. Biocon Description and Overview
Table 131. Biocon Human Insulin Sales Quantity (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2018-2023)
Table 132. Biocon Human Insulin Product and Services
Table 133. Biocon Human Insulin SWOT Analysis
Table 134. Biocon Recent Developments
Table 135. Biodel Company Information
Table 136. Biodel Description and Overview
Table 137. Biodel Human Insulin Sales Quantity (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2018-2023)
Table 138. Biodel Human Insulin Product and Services
Table 139. Biodel Human Insulin SWOT Analysis
Table 140. Biodel Recent Developments
Table 141. ELI Lilly Company Information
Table 142. ELI Lilly Description and Overview
Table 143. ELI Lilly Human Insulin Sales Quantity (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2018-2023)
Table 144. ELI Lilly Human Insulin Product and Services
Table 145. ELI Lilly Human Insulin SWOT Analysis
Table 146. ELI Lilly Recent Developments
Table 147. Julphar Company Information
Table 148. Julphar Description and Overview
Table 149. Julphar Human Insulin Sales Quantity (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2018-2023)
Table 150. Julphar Human Insulin Product and Services
Table 151. Julphar Human Insulin SWOT Analysis
Table 152. Julphar Recent Developments
Table 153. NOVO Nordisk Company Information
Table 154. NOVO Nordisk Description and Overview
Table 155. NOVO Nordisk Human Insulin Sales Quantity (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2018-2023)
Table 156. NOVO Nordisk Human Insulin Product and Services
Table 157. NOVO Nordisk Human Insulin SWOT Analysis
Table 158. NOVO Nordisk Recent Developments
Table 159. Sanofi Company Information
Table 160. Sanofi Description and Overview
Table 161. Sanofi Human Insulin Sales Quantity (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2018-2023)
Table 162. Sanofi Human Insulin Product and Services
Table 163. Sanofi Human Insulin SWOT Analysis
Table 164. Sanofi Recent Developments
Table 165. Wockhardt Company Information
Table 166. Wockhardt Description and Overview
Table 167. Wockhardt Human Insulin Sales Quantity (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2018-2023)
Table 168. Wockhardt Human Insulin Product and Services
Table 169. Wockhardt Human Insulin SWOT Analysis
Table 170. Wockhardt Recent Developments
Table 171. Ypsomed Company Information
Table 172. Ypsomed Description and Overview
Table 173. Ypsomed Human Insulin Sales Quantity (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2018-2023)
Table 174. Ypsomed Human Insulin Product and Services
Table 175. Ypsomed Human Insulin SWOT Analysis
Table 176. Ypsomed Recent Developments
Table 177. Key Raw Materials Lists
Table 178. Raw Materials Key Suppliers Lists
Table 179. Human Insulin Distributors List
Table 180. Human Insulin Customers List
Table 181. Human Insulin Market Trends
Table 182. Human Insulin Market Drivers
Table 183. Human Insulin Market Challenges
Table 184. Human Insulin Market Restraints
Table 185. Research Programs/Design for This Report
Table 186. Key Data Information from Secondary Sources
Table 187. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Insulin Product Picture
Figure 2. Global Human Insulin Market Size Growth Rate by Type, 2018 VS 2024 VS 2034 (US$ Million)
Figure 3. Global Human Insulin Market Share by Type in 2024 & 2034
Figure 4. Insulin Analogs and Biosimilars Product Picture
Figure 5. Human Insulin Biologics Product Picture
Figure 6. Global Human Insulin Market Size Growth Rate by Application, 2018 VS 2024 VS 2034 (US$ Million)
Figure 7. Global Human Insulin Market Share by Application in 2024 & 2034
Figure 8. Short Acting
Figure 9. Intermediate Acting
Figure 10. Long Acting
Figure 11. Pre-Mix Insulin
Figure 12. Human Insulin Report Years Considered
Figure 13. Global Human Insulin Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 14. Global Human Insulin Revenue 2018-2034 (US$ Million)
Figure 15. Global Human Insulin Revenue Market Share by Region in Percentage: 2024 Versus 2034
Figure 16. Global Human Insulin Sales Quantity 2018-2034 (K Doses)
Figure 17. Global Human Insulin Sales Quantity Market Share by Region (2018-2023)
Figure 18. Global Human Insulin Sales Quantity Market Share by Region (2024-2034)
Figure 19. North America Human Insulin Sales Quantity YoY (2018-2034) & (K Doses)
Figure 20. North America Human Insulin Revenue YoY (2018-2034) & (US$ Million)
Figure 21. Europe Human Insulin Sales Quantity YoY (2018-2034) & (K Doses)
Figure 22. Europe Human Insulin Revenue YoY (2018-2034) & (US$ Million)
Figure 23. China Human Insulin Sales Quantity YoY (2018-2034) & (K Doses)
Figure 24. China Human Insulin Revenue YoY (2018-2034) & (US$ Million)
Figure 25. APAC Human Insulin Sales Quantity YoY (2018-2034) & (K Doses)
Figure 26. APAC Human Insulin Revenue YoY (2018-2034) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Human Insulin Sales Quantity YoY (2018-2034) & (K Doses)
Figure 28. Middle East, Africa and Latin America Human Insulin Revenue YoY (2018-2034) & (US$ Million)
Figure 29. The Top 10 and Top 5 Players Market Share by Human Insulin Sales Quantity in 2024
Figure 30. The Top 10 and Top 5 Players Market Share by Human Insulin Revenue in 2024
Figure 31. Human Insulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2024
Figure 32. Global Human Insulin Sales Quantity Market Share by Type (2018-2034)
Figure 33. Global Human Insulin Revenue Market Share by Type (2018-2034)
Figure 34. Global Human Insulin Sales Quantity Market Share by Application (2018-2034)
Figure 35. Global Human Insulin Revenue Market Share by Application (2018-2034)
Figure 36. North America Human Insulin Revenue Market Share by Company in 2024
Figure 37. North America Human Insulin Sales Quantity Market Share by Company in 2024
Figure 38. North America Human Insulin Sales Quantity Market Share by Type (2018-2034)
Figure 39. North America Human Insulin Revenue Market Share by Type (2018-2034)
Figure 40. North America Human Insulin Sales Quantity Market Share by Application (2018-2034)
Figure 41. North America Human Insulin Revenue Market Share by Application (2018-2034)
Figure 42. North America Human Insulin Revenue Share by Country (2018-2034)
Figure 43. North America Human Insulin Sales Quantity Share by Country (2018-2034)
Figure 44. U.S. Human Insulin Revenue (2018-2034) & (US$ Million)
Figure 45. Canada Human Insulin Revenue (2018-2034) & (US$ Million)
Figure 46. Europe Human Insulin Sales Quantity Market Share by Company in 2024
Figure 47. Europe Human Insulin Revenue Market Share by Company in 2024
Figure 48. Europe Human Insulin Sales Quantity Market Share by Type (2018-2034)
Figure 49. Europe Human Insulin Revenue Market Share by Type (2018-2034)
Figure 50. Europe Human Insulin Sales Quantity Market Share by Application (2018-2034)
Figure 51. Europe Human Insulin Revenue Market Share by Application (2018-2034)
Figure 52. Europe Human Insulin Revenue Share by Country (2018-2034)
Figure 53. Europe Human Insulin Sales Quantity Share by Country (2018-2034)
Figure 54. Germany Human Insulin Revenue (2018-2034) & (US$ Million)
Figure 55. France Human Insulin Revenue (2018-2034) & (US$ Million)
Figure 56. U.K. Human Insulin Revenue (2018-2034) & (US$ Million)
Figure 57. Italy Human Insulin Revenue (2018-2034) & (US$ Million)
Figure 58. Russia Human Insulin Revenue (2018-2034) & (US$ Million)
Figure 59. China Human Insulin Sales Quantity Market Share by Company in 2024
Figure 60. China Human Insulin Revenue Market Share by Company in 2024
Figure 61. China Human Insulin Sales Quantity Market Share by Type (2018-2034)
Figure 62. China Human Insulin Revenue Market Share by Type (2018-2034)
Figure 63. China Human Insulin Sales Quantity Market Share by Application (2018-2034)
Figure 64. China Human Insulin Revenue Market Share by Application (2018-2034)
Figure 65. APAC Human Insulin Sales Quantity Market Share by Company in 2024
Figure 66. APAC Human Insulin Revenue Market Share by Company in 2024
Figure 67. APAC Human Insulin Sales Quantity Market Share by Type (2018-2034)
Figure 68. APAC Human Insulin Revenue Market Share by Type (2018-2034)
Figure 69. APAC Human Insulin Sales Quantity Market Share by Application (2018-2034)
Figure 70. APAC Human Insulin Revenue Market Share by Application (2018-2034)
Figure 71. APAC Human Insulin Revenue Share by Region (2018-2034)
Figure 72. APAC Human Insulin Sales Quantity Share by Region (2018-2034)
Figure 73. Japan Human Insulin Revenue (2018-2034) & (US$ Million)
Figure 74. South Korea Human Insulin Revenue (2018-2034) & (US$ Million)
Figure 75. China Taiwan Human Insulin Revenue (2018-2034) & (US$ Million)
Figure 76. Southeast Asia Human Insulin Revenue (2018-2034) & (US$ Million)
Figure 77. India Human Insulin Revenue (2018-2034) & (US$ Million)
Figure 78. Middle East, Africa and Latin America Human Insulin Sales Quantity Market Share by Company in 2024
Figure 79. Middle East, Africa and Latin America Human Insulin Revenue Market Share by Company in 2024
Figure 80. Middle East, Africa and Latin America Human Insulin Sales Quantity Market Share by Type (2018-2034)
Figure 81. Middle East, Africa and Latin America Human Insulin Revenue Market Share by Type (2018-2034)
Figure 82. Middle East, Africa and Latin America Human Insulin Sales Quantity Market Share by Application (2018-2034)
Figure 83. Middle East, Africa and Latin America Human Insulin Revenue Market Share by Application (2018-2034)
Figure 84. Middle East, Africa and Latin America Human Insulin Sales Quantity Share by Country (2018-2034)
Figure 85. Middle East, Africa and Latin America Human Insulin Revenue Share by Country (2018-2034)
Figure 86. Brazil Human Insulin Revenue (2018-2034) & (US$ Million)
Figure 87. Mexico Human Insulin Revenue (2018-2034) & (US$ Million)
Figure 88. Turkey Human Insulin Revenue (2018-2034) & (US$ Million)
Figure 89. Israel Human Insulin Revenue (2018-2034) & (US$ Million)
Figure 90. GCC Countries Human Insulin Revenue (2018-2034) & (US$ Million)
Figure 91. Human Insulin Value Chain
Figure 92. Human Insulin Production Process
Figure 93. Channels of Distribution (Direct Vs Distribution)
Figure 94. Distributors Profiles
Figure 95. Bottom-up and Top-down Approaches for This Report
Figure 96. Data Triangulation
Figure 97. Key Executives Interviewed